J H Sohn

Summary

Affiliation: Hallym University
Country: Korea

Publications

  1. ncbi Fine needle aspiration cytologic findings of breast mucinous neoplasms: differential diagnosis between mucocelelike tumor and mucinous carcinoma
    J H Sohn
    Department of Pathology, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea
    Acta Cytol 45:723-9. 2001
  2. doi A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
    K H Park
    Division of Oncology Hematology, Department of Internal Medicine, Korea University College of Medicine, 97 Guro Dong Gil, Guro Gu, Seoul, Korea
    Invest New Drugs 31:1300-6. 2013
  3. ncbi Effect of adding TS-1 to neoadjuvant chemotherapy in HER2-negative, stage II-III breast cancer in a single-arm phase ll study
    S Lee
    Yonsei Cancer Center Devision of Medical Oncology Department of Internal Medicine Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
    J Clin Oncol 29:e11549. 2011
  4. ncbi Reduced expression of the cell-cycle inhibitor p27Kip1 is associated with progression and lymph node metastasis of gastric carcinoma
    D H Kim
    Department of Pathology, College of Medicine, Hallym University, Seoul, Korea
    Histopathology 36:245-51. 2000
  5. ncbi Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias
    J H Sohn
    Departments of Pathology, College of Medicine, Hallym University, Seoul, Korea
    Histopathology 37:555-60. 2000
  6. ncbi Prognostic index for patients with brain metastases from breast cancer: A validation and refinement of the breast-specific graded prognostic assessment (GPA) index
    H K Ahn
    Division of Hematology Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Yonsei Cancer Center Devision of Medical Oncology Department of Internal Medicine Yonsei University College of Medicine, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Samsung Medical Center, Seoul, South Korea Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
    J Clin Oncol 29:1097. 2011
  7. pmc Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    Department of Oncology Hematology, Kyungpook National University, College of Medicine, Kyungpook National University Hospital, Daegu, Korea
    Br J Cancer 93:1117-21. 2005
  8. pmc Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study
    M J Ahn
    Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
    J Korean Med Sci 13:612-6. 1998
  9. ncbi Primary synovial sarcoma of the kidney
    D H Kim
    Department of Pathology, Hallym University College of Medicine, Seoul, Korea
    Am J Surg Pathol 24:1097-104. 2000
  10. ncbi Prolonged clinical benefit with the maintenance hormone therapy in patients with metastatic breast cancer
    S Lim
    Yonsei Cancer Center, Seoul, South Korea Yonsei University College of Medicine, Seoul, South Korea Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
    J Clin Oncol 29:e11051. 2011

Collaborators

Detail Information

Publications13

  1. ncbi Fine needle aspiration cytologic findings of breast mucinous neoplasms: differential diagnosis between mucocelelike tumor and mucinous carcinoma
    J H Sohn
    Department of Pathology, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea
    Acta Cytol 45:723-9. 2001
    ..To report the cytologic findings of mucocelelike tumor and mucinous carcinoma...
  2. doi A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
    K H Park
    Division of Oncology Hematology, Department of Internal Medicine, Korea University College of Medicine, 97 Guro Dong Gil, Guro Gu, Seoul, Korea
    Invest New Drugs 31:1300-6. 2013
    ..The aim of this study was to evaluate the efficacy and safety of once-per-cycle DA-3031 in patients receiving chemotherapy for breast cancer...
  3. ncbi Effect of adding TS-1 to neoadjuvant chemotherapy in HER2-negative, stage II-III breast cancer in a single-arm phase ll study
    S Lee
    Yonsei Cancer Center Devision of Medical Oncology Department of Internal Medicine Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
    J Clin Oncol 29:e11549. 2011
    ..4:1 that has limited evidence for use in breast cancer. This study's purpose was to determine the efficacy the doxorubicin/cyclophosphamide (AC) followed by docetaxel and TS-1 (DS) in the preoperative setting...
  4. ncbi Reduced expression of the cell-cycle inhibitor p27Kip1 is associated with progression and lymph node metastasis of gastric carcinoma
    D H Kim
    Department of Pathology, College of Medicine, Hallym University, Seoul, Korea
    Histopathology 36:245-51. 2000
    ..Decreased expression of p27 is associated with high histological grade and aggressiveness of several human tumours. We aimed to evaluate the role of p27 in the progression and metastasis of gastric carcinoma...
  5. ncbi Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias
    J H Sohn
    Departments of Pathology, College of Medicine, Hallym University, Seoul, Korea
    Histopathology 37:555-60. 2000
    ..The aim of this study was to determine whether caspase-3 is expressed in prostatic carcinoma and benign prostatic hyperplasia, and correlated with the apoptosis...
  6. ncbi Prognostic index for patients with brain metastases from breast cancer: A validation and refinement of the breast-specific graded prognostic assessment (GPA) index
    H K Ahn
    Division of Hematology Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Yonsei Cancer Center Devision of Medical Oncology Department of Internal Medicine Yonsei University College of Medicine, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Samsung Medical Center, Seoul, South Korea Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
    J Clin Oncol 29:1097. 2011
    ..IJROBP. 2010) and modified (ASCO 2010 abst. #1028) to reflect unique biologic feature of BC. The purpose of this study is to appraise and refine the Sperduto's BC-specific GPA index (S' GPA)...
  7. pmc Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    Department of Oncology Hematology, Kyungpook National University, College of Medicine, Kyungpook National University Hospital, Daegu, Korea
    Br J Cancer 93:1117-21. 2005
    ..8 and 57.9%, respectively. Concurrent chemoradiotherapy with capecitabine and cisplatin was found to be well tolerated and effective in patients with locally advanced SCCHN...
  8. pmc Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study
    M J Ahn
    Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
    J Korean Med Sci 13:612-6. 1998
    ..These data support that the combinations of oral 5'-DFUR and cisplatin are well tolerable and have a moderate activity with low toxicity in the treatment of advanced gastric cancer...
  9. ncbi Primary synovial sarcoma of the kidney
    D H Kim
    Department of Pathology, Hallym University College of Medicine, Seoul, Korea
    Am J Surg Pathol 24:1097-104. 2000
    ..One patient died 10 months after diagnosis. These tumors are unique cases of primary synovial sarcoma of the kidney confirmed by molecular study...
  10. ncbi Prolonged clinical benefit with the maintenance hormone therapy in patients with metastatic breast cancer
    S Lim
    Yonsei Cancer Center, Seoul, South Korea Yonsei University College of Medicine, Seoul, South Korea Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
    J Clin Oncol 29:e11051. 2011
    ..We evaluated the efficacy of MHT and identify those who benefit most from maintenance hormone therapy...
  11. doi Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
    H R Kim
    Division of Medical Oncology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
    Ann Oncol 24:1485-90. 2013
    ..This phase II neoadjuvant trial evaluated bevacizumab-docetaxel and carboplatin in triple-negative breast cancer...
  12. ncbi Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms
    E Y Cho
    Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon Dong, Kangnam Gu, Seoul 135 710, Korea
    Int J Gynecol Cancer 16:1000-6. 2006
    ....
  13. ncbi Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer
    D H Kim
    Departments of Pathology and General Surgery, College of Medicine, Hallym University, Seoul, Korea
    Histopathology 42:37-42. 2003
    ..However, its precise role in human breast cancer remains to be discovered. We aimed to evaluate the role of maspin in early-stage breast cancer...